Sherb Eric Michael has officially filed a Form 3, reporting his position as Chief Financial Officer at Apimeds Pharmaceuticals US, Inc. This filing is significant as it underscores the company's dedication to transparency regarding its executive leadership.

Apimeds Pharmaceuticals US, Inc. operates in the pharmaceutical preparations sector, which is critical for ensuring the availability of medications and treatments. As a company incorporated in Delaware, Apimeds is subject to various regulatory requirements that govern its operations and disclosures.

The filing states that Sherb Eric Michael is an officer of the company, confirming his role within the organization. The address listed for him is 8913 Regents Park Drive, Suite 550, Tampa, FL 33647. The filing was made as of November 2, 2026, and it indicates that he holds no securities owned.

This update may affect stakeholders within Apimeds Pharmaceuticals, as well as investors and analysts monitoring the pharmaceutical industry. Increased transparency from executives can lead to greater investor confidence and may influence how competitors approach their own disclosures.

The filing does not say what happens next.

Company Overview

Apimeds Pharmaceuticals US, Inc. is classified under the Standard Industrial Classification (SIC) code 2834, which pertains to pharmaceutical preparations. This classification highlights the company's focus on the development and distribution of medications, a critical area within the life sciences sector. The company is incorporated in Delaware and operates with a fiscal year ending on December 31.

Contact Information

The business address for Apimeds Pharmaceuticals is located at 100 Matawan Rd, Suite 325, Matawan, NJ 07747. Stakeholders can reach the company via their business phone number, 848-201-5010, for inquiries related to corporate governance or operations.

The filing does not include details on any future plans or strategies that Sherb Eric Michael may implement as Chief Financial Officer.